Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units | Zendy

Seilesh Kadambari | Zendy; Paul T. Heath | Zendy; Mike Sharland | Zendy; Susan J. Lewis | Zendy; Alice I. Nichols | Zendy; M. Turner | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units

Author(s) -

Seilesh Kadambari,

Paul T. Heath,

Mike Sharland,

Susan J. Lewis,

Alice I. Nichols,

M. Turner

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr351

Subject(s) - vancomycin , gentamicin , therapeutic drug monitoring , medicine , antibiotics , regimen , intensive care medicine , drug , pharmacology , staphylococcus aureus , microbiology and biotechnology , biology , bacteria , genetics

Gentamicin and vancomycin are commonly used in neonatal units for the treatment of life-threatening infections. This study aimed to describe the dosage regimen and the approach to therapeutic drug monitoring (TDM) for both antibiotics in units that participate in a UK neonatal network.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research